Pyxis Oncology (PYXS) EPS (Basic) (2020 - 2025)

Pyxis Oncology's (PYXS) quarterly EPS (Basic) came in at -$0.3 in Q4 2025, up 51.38% year-on-year from -$0.2 in Q4 2024, and up 15.87% on a QoQ basis from -$0.35 in Q3 2025.

Pyxis Oncology (PYXS) EPS (Basic) (2020 - 2025) Analysis & Trends

Pyxis Oncology (PYXS) has 6 years of EPS (Basic) data on file, last reported at -$0.3 in Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 51.38% year-over-year to -$0.3 in Q4 2025; TTM through Dec 2025 was -$1.31, a 10.89% increase from a year earlier, with the FY2025 full-year figure at -$1.28, up 3.16% from the prior year.
  • EPS (Basic) for Q4 2025 stood at -$0.3, up from -$0.35 in the prior quarter.
  • Over the last five years, EPS (Basic) for PYXS reached as high as -$0.23 in Q1 2024 and fell as low as -$29.32 in Q3 2021.
  • Historically, EPS (Basic) has averaged -$3.66 across 5 years, with a median of -$0.59 in 2023.
  • Across the five-year window, EPS (Basic) plunged 899.84% in 2021 and soared 96.28% in 2022, its largest moves.
  • Year by year, EPS (Basic) stood at -$3.87 in 2021, then surged by 72.23% to -$1.07 in 2022, then soared by 58.98% to -$0.44 in 2023, then sank by 38.2% to -$0.61 in 2024, then soared by 51.38% to -$0.3 in 2025.
  • Per Business Quant data, the three most recent EPS (Basic) figures were -$0.3 in Q4 2025, -$0.35 in Q3 2025, and -$0.3 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.16
4 NuCana 279.75 Bn 279.75 Bn - 0.00
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.99
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.59
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Pyxis Oncology 166.54 Mn 99.69 Mn 8.65 Mn -0.30

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.30
Sep 30, 2025 -0.35
Jun 30, 2025 -0.30
Mar 31, 2025 -0.37
Dec 31, 2024 -0.61
Sep 30, 2024 -0.35
Jun 30, 2024 -0.29
Mar 31, 2024 -0.23
Dec 31, 2023 -0.44
Sep 30, 2023 -0.58
Jun 30, 2023 -0.47
Mar 31, 2023 -0.72
Dec 31, 2022 -1.07
Sep 30, 2022 -1.25
Jun 30, 2022 -1.20
Mar 31, 2022 -0.98
Dec 31, 2021 -3.87
Sep 30, 2021 -29.32
Jun 30, 2021 -4.03
Mar 31, 2021 -26.45